Auswahl der wissenschaftlichen Literatur zum Thema „Transmembrane mucins“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Transmembrane mucins" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Transmembrane mucins"

1

van Putten, Jos P. M., und Karin Strijbis. „Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer“. Journal of Innate Immunity 9, Nr. 3 (2017): 281–99. http://dx.doi.org/10.1159/000453594.

Der volle Inhalt der Quelle
Annotation:
Mucosal surfaces line our body cavities and provide the interaction surface between commensal and pathogenic microbiota and the host. The barrier function of the mucosal layer is largely maintained by gel-forming mucin proteins that are secreted by goblet cells. In addition, mucosal epithelial cells express cell-bound mucins that have both barrier and signaling functions. The family of transmembrane mucins consists of diverse members that share a few characteristics. The highly glycosylated extracellular mucin domains inhibit invasion by pathogenic bacteria and can form a tight mesh structure that protects cells in harmful conditions. The intracellular tails of transmembrane mucins can be phosphorylated and connect to signaling pathways that regulate inflammation, cell-cell interactions, differentiation, and apoptosis. Transmembrane mucins play important roles in preventing infection at mucosal surfaces, but are also renowned for their contributions to the development, progression, and metastasis of adenocarcinomas. In general, transmembrane mucins seem to have evolved to monitor and repair damaged epithelia, but these functions can be highjacked by cancer cells to yield a survival advantage. This review presents an overview of the current knowledge of the functions of transmembrane mucins in inflammatory processes and carcinogenesis in order to better understand the diverse functions of these multifunctional proteins.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Sun, Lingbo, Yuhan Zhang, Wenyan Li, Jing Zhang und Yuecheng Zhang. „Mucin Glycans: A Target for Cancer Therapy“. Molecules 28, Nr. 20 (11.10.2023): 7033. http://dx.doi.org/10.3390/molecules28207033.

Der volle Inhalt der Quelle
Annotation:
Mucin glycans are an important component of the mucus barrier and a vital defence against physical and chemical damage as well as pathogens. There are 20 mucins in the human body, which can be classified into secreted mucins and transmembrane mucins according to their distributions. The major difference between them is that secreted mucins do not have transmembrane structural domains, and the expression of each mucin is organ and cell-specific. Under physiological conditions, mucin glycans are involved in the composition of the mucus barrier and thus protect the body from infection and injury. However, abnormal expression of mucin glycans can lead to the occurrence of diseases, especially cancer, through various mechanisms. Therefore, targeting mucin glycans for the diagnosis and treatment of cancer has always been a promising research direction. Here, we first summarize the main types of glycosylation (O-GalNAc glycosylation and N-glycosylation) on mucins and the mechanisms by which abnormal mucin glycans occur. Next, how abnormal mucin glycans contribute to cancer development is described. Finally, we summarize MUC1-based antibodies, vaccines, radio-pharmaceuticals, and CAR-T therapies using the best characterized MUC1 as an example. In this section, we specifically elaborate on the recent new cancer therapy CAR-M, which may bring new hope to cancer patients.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Ballester, Milara und Cortijo. „Mucins as a New Frontier in Pulmonary Fibrosis“. Journal of Clinical Medicine 8, Nr. 9 (11.09.2019): 1447. http://dx.doi.org/10.3390/jcm8091447.

Der volle Inhalt der Quelle
Annotation:
Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pulmonary disease with a median survival of 3–5 years after diagnosis. Recent evidence identifies mucins as key effectors in cell growth and tissue remodeling processes compatible with the processes observed in IPF. Mucins are classified in two groups depending on whether they are secreted (secreted mucins) or tethered to cell membranes (transmembrane mucins). Secreted mucins (MUC2, MUC5AC, MUC5B, MUC6-8 and MUC19) are released to the extracellular medium and recent evidence has shown that a promoter polymorphism in the secreted mucin MUC5B is associated with IPF risk. Otherwise, transmembrane mucins (MUC1, MUC3, MUC4, MUC12-17 and MUC20) have a receptor-like structure, sensing the external environment and activating intracellular signal transduction pathways essential for mucosal maintenance and damage repair. In this context, the extracellular domain can be released to the external environment by metalloproteinase action, increased in IPF, thus activating fibrotic processes. For example, several studies have reported increased serum extracellular secreted KL6/MUC1 during IPF acute exacerbation. Moreover, MUC1 and MUC4 overexpression in the main IPF cells has been observed. In this review we summarize the current knowledge of mucins as promising druggable targets for IPF.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Chatterjee, Maitrayee, Liane Z. X. Huang, Anna Z. Mykytyn, Chunyan Wang, Mart M. Lamers, Bart Westendorp, Richard W. Wubbolts et al. „Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface“. PLOS Pathogens 19, Nr. 8 (10.08.2023): e1011571. http://dx.doi.org/10.1371/journal.ppat.1011571.

Der volle Inhalt der Quelle
Annotation:
Mucins play an essential role in protecting the respiratory tract against microbial infections while also acting as binding sites for bacterial and viral adhesins. The heavily O-glycosylated gel-forming mucins MUC5AC and MUC5B eliminate pathogens by mucociliary clearance. Transmembrane mucins MUC1, MUC4, and MUC16 can restrict microbial invasion at the apical surface of the epithelium. In this study, we determined the impact of host mucins and mucin glycans on epithelial entry of SARS-CoV-2. Human lung epithelial Calu-3 cells express the SARS-CoV-2 entry receptor ACE2 and high levels of glycosylated MUC1, but not MUC4 and MUC16, on their cell surface. The O-glycan-specific mucinase StcE specifically removed the glycosylated part of the MUC1 extracellular domain while leaving the underlying SEA domain and cytoplasmic tail intact. StcE treatment of Calu-3 cells significantly enhanced infection with SARS-CoV-2 pseudovirus and authentic virus, while removal of sialic acid and fucose from the epithelial surface did not impact viral entry. In Calu-3 cells, the transmembrane mucin MUC1 and ACE2 are located to the apical surface in close proximity and StcE treatment results in enhanced binding of purified spike protein. Both MUC1 and MUC16 are expressed on the surface of human organoid-derived air-liquid interface (ALI) differentiated airway cultures and StcE treatment led to mucin removal and increased levels of SARS-CoV-2 replication. In these cultures, MUC1 was highly expressed in non-ciliated cells while MUC16 was enriched in goblet cells. In conclusion, the glycosylated extracellular domains of different transmembrane mucins might have similar protective functions in different respiratory cell types by restricting SARS-CoV-2 binding and entry.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Hauber, Hans-Peter, Susan C. Foley und Qutayba Hamid. „Mucin Overproduction in Chronic Inflammatory Lung Disease“. Canadian Respiratory Journal 13, Nr. 6 (2006): 327–35. http://dx.doi.org/10.1155/2006/901417.

Der volle Inhalt der Quelle
Annotation:
Mucus overproduction and hypersecretion are commonly observed in chronic inflammatory lung disease. Mucins are gel-forming glycoproteins that can be stimulated by a variety of mediators. The present review addresses the mechanisms involved in the upregulation of secreted mucins. Mucin induction by neutrophil elastase, bacteria, cytokines, growth factors, smoke and cystic fibrosis transmembrane conductance regulator malfunction are also discussed.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Constantinou, Pamela E., Brian P. Danysh, Neeraja Dharmaraj und Daniel D. Carson. „Transmembrane mucins as novel therapeutic targets“. Expert Review of Endocrinology & Metabolism 6, Nr. 6 (November 2011): 835–48. http://dx.doi.org/10.1586/eem.11.70.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Hansson, Gunnar C. „Mucins and the Microbiome“. Annual Review of Biochemistry 89, Nr. 1 (20.06.2020): 769–93. http://dx.doi.org/10.1146/annurev-biochem-011520-105053.

Der volle Inhalt der Quelle
Annotation:
Generating the barriers that protect our inner surfaces from bacteria and other challenges requires large glycoproteins called mucins. These come in two types, gel-forming and transmembrane, all characterized by large, highly O-glycosylated mucin domains that are diversely decorated by Golgi glycosyltransferases to become extended rodlike structures. The general functions of mucins on internal epithelial surfaces are to wash away microorganisms and, even more importantly, to build protective barriers. The latter function is most evident in the large intestine, where the inner mucus layer separates the numerous commensal bacteria from the epithelial cells. The host's conversion of MUC2 to the outer mucus layer allows bacteria to degrade the mucin glycans and recover the energy content that is then shared with the host. The molecular nature of the mucins is complex, and how they construct the extracellular complex glycocalyx and mucus is poorly understood and a future biochemical challenge.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Mall, A. S. „Analysis of mucins: role in laboratory diagnosis“. Journal of Clinical Pathology 61, Nr. 9 (19.07.2008): 1018–24. http://dx.doi.org/10.1136/jcp.2008.058057.

Der volle Inhalt der Quelle
Annotation:
Mucins are high molecular weight glycoproteins with complex oligosaccharide side chains attached to the apomucin protein backbone by O-glycosidic linkage; they are found in crude mucus gels that protect epithelial surfaces in the major tracts of the body and as transmembrane proteins expressed on the apical cell surface of glandular and ductal epithelia of various organs. Changes in the sequence of glycosylation of mucins in different settings generate a variety of epitopes in the oligosaccharide side chains of mucins, including newly expressed blood-group antigens, distinguishing between normal and diseased states. Tumour-associated epitopes on mucins and their antigenicity make them suitable as immunotargets on malignant epithelial cells and their secretions, creating a surge of interest in mucins as diagnostic and prognostic markers for various diseases, and even influencing the design of mucin-based vaccines. This review discusses the emerging roles of mucins such as MUC1 and MUC4 in cancer and some other diseases, and stresses how underglycosylated and truncated mucins are exploited as markers of disease and to monitor widespread metastasis, making them useful in patient management. Furthermore the type, pattern and amount of mucin secreted in some tissues have been considered in the classification and terminology of neoplasia and in specific organs such as the pancreas. These factors have been instrumental in pathological classification, diagnosis and prognostication of neoplasia.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Itah, Shir, David Elad, Ariel J. Jaffa, Dan Grisaru und Mordechai Rosner. „Transmembrane Mucin Response in Conjunctival Epithelial Cells Exposed to Wall Shear Stresses“. International Journal of Molecular Sciences 24, Nr. 7 (01.04.2023): 6589. http://dx.doi.org/10.3390/ijms24076589.

Der volle Inhalt der Quelle
Annotation:
Human conjunctival epithelium cells (HCEC) line the inner surface of the eyelid and cover the sclera and are continuously subjected to wall shear stresses (WSS). The effects of external forces on the conjunctival epithelium are not fully known. The conjunctival epithelium contains stratified squamous cells that synthesize the membrane-spanning mucins MUC1 and MUC16, which play important roles in protecting the ocular surface. Alterations in both gel-forming and membrane-tethered mucins occur in drying ocular surface diseases. The aim of this study was to explore the mechanobiological characteristics of transmembrane mucin secretion and cellular alterations of primary HCEC exposed to airflow-induced WSS perturbations. We exposed the HCEC to a steady WSS of 0.5 dyne/cm2 for durations of 15 and 30 min. Cytoskeletal alterations and MUC1 secretions were studied using immunohistochemically fluorescent staining with specific antibodies. We investigated for the first time an in vitro model of membrane-tethered mucin secretion by HCEC in response to WSS. The exposure of HCEC to WSS increased the polymerization of F-actin, altered the cytoskeletal shape and reduced the secretion of membrane-tethered MUC1.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Kramer, Jessica R., Bibiana Onoa, Carlos Bustamante und Carolyn R. Bertozzi. „Chemically tunable mucin chimeras assembled on living cells“. Proceedings of the National Academy of Sciences 112, Nr. 41 (29.09.2015): 12574–79. http://dx.doi.org/10.1073/pnas.1516127112.

Der volle Inhalt der Quelle
Annotation:
Mucins are a family of secreted and transmembrane glycoproteins characterized by a massive domain of dense O-glycosylation on serine and threonine residues. Mucins are intimately involved in immunity and cancer, yet elucidation of the biological roles of their glycodomains has been complicated by their massive size, domain polymorphisms, and variable glycosylation patterns. Here we developed a synthetic route to a library of compositionally defined, high-molecular weight, dual end-functionalized mucin glycodomain constructs via N-carboxyanhydride polymerization. These glycopolypeptides are the first synthetic analogs to our knowledge to feature the native α-GalNAc linkage to serine with molecular weights similar to native mucins, solving a nearly 50-year synthetic challenge. Physical characterization of the mimics revealed insights into the structure and properties of mucins. The synthetic glycodomains were end-functionalized with an optical probe and a tetrazine moiety, which allowed site-specific bioorthogonal conjugation to an engineered membrane protein on live mammalian cells. This strategy in protein engineering will open avenues to explore the biological roles of cell surface mucins.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Dissertationen zum Thema "Transmembrane mucins"

1

Lang, Tiange. „Evolution of transmembrane and gel-forming mucins studied with bioinformatic methods /“. Göteborg : The Sahlgrenska Academy at Göteborg University, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, 2007. http://hdl.handle.net/2077/7502.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Ammam, Ianis. „Études et caractérisations tribologiques des mécanismes biophysiques de la lubrification orale“. Electronic Thesis or Diss., Ecully, Ecole centrale de Lyon, 2024. http://www.theses.fr/2024ECDL0042.

Der volle Inhalt der Quelle
Annotation:
L’étude de la lubrification orale devient une problématique actuelle pour l’industrie agroalimentaire. Les analyses quantitatives permettent de comprendre et d’anticiper des mécanismes physiologiques, tels que la prédiction des phénomènes d’astringence des produits alimentaires. L’astringence se manifeste par une diminution de la lubrification de la muqueuse orale après la consommation de produits d’origine végétale. Cependant, les recherches actuelles sur la lubrification orale s’appuient sur des matériaux synthétiques qui représentent mal les tissus buccaux. Elles négligent les interactions entre les protéines salivaires sécrétées et les protéines transmembranaires, limitant ainsi la compréhension des mécanismes de lubrification.Cette thèse s’inscrit dans le projet MACARON qui vise à étudier le rôle de la muqueuse orale dans la perception sensorielle. Des modèles in vitro de muqueuse orale qui expriment la protéine transmembranaire MUC1 ont été développés pour simuler les interactions fondamentales entre MUC1 et les protéines salivaires. Ces interactions sont responsables de la lubrification et de l’hydratation des tissus. Par ailleurs, un tribomètre a été conçu pour effectuer des tests tribologiques in vitro sur ces modèles d’épithélium afin de suivre leur état de lubrification.Cette thèse se concentre ainsi sur l’étude des mécanismes moléculaires de la lubrification orale à travers une approche tribologique in vitro, en utilisant des paramètres physiques macro et micrométriques. Ce manuscrit propose en premier lieu une étude sur le rôle crucial de la mucine MUC1 et de sa structure dans la lubrification orale. La présence de MUC1 améliore la lubrification grâce à une meilleure rétention des protéines salivaires à la surface cellulaire. Ensuite, le manuscrit présente une exploration des mécanismes moléculaires de l’astringence. Les essais tribologiques in vitro en présence de composés astringents montrent que ces substances forment des agrégations à la surface épithéliale qui diminuent la lubrification orale. Parallèlement, nos travaux montrent que des mécanismes de protection, notamment la dissociation de MUC1 et l’interaction des protéines riches en proline avec les tanins, atténuent ces effets néfastes sur la lubrification.À travers une étude complémentaire, des corrélations entre la perception sensorielle et nos propriétés physiques mesurées sont établies, démontrant la capacité de notre méthodologie à classer des individus selon leur sensibilité à l’astringence. Enfin, la dernière étude présente le développement d’un nouveau modèle de muqueuse orale visant à reproduire les propriétés mécaniques et physico-chimiques de la muqueuse in vivo.Cette thèse propose une méthodologie innovante pour l’étude de la lubrification orale, en particulier en s’intéressant à des mécanismes responsables de la sensation d’astringence grâce à l’utilisation de modèles de muqueuse toujours plus proches des tissus oraux physiologiques
The study of oral lubrication has become a current concern for the food industry. Quantitative analyses allow for understanding and anticipating physiological mechanisms, such as predicting astringency phenomena in food products. Astringency is characterized by a decrease in oral mucosa lubrication following the consumption of plant-based products. However, current research on oral lubrication relies on synthetic materials that poorly represent oral tissues, neglecting interactions between secreted salivary proteins and transmembrane proteins, thus limiting the understanding of lubrication mechanisms. This thesis is part of the MACARON project, which aims to investigate the role of oral mucosa in sensory perception. In vitro models of oral mucosa expressing the transmembrane protein MUC1 have been developed to simulate fundamental interactions between MUC1 and salivary proteins responsible for tissue lubrication and hydration. Additionally, a tribometer has been designed to perform in vitro tribological tests on these epithelial models to monitor their lubrication state. Thus, this thesis focuses on studying the molecular mechanisms of oral lubrication through an in vitro tribological approach, using macro- and micrometric physical parameters. Firstly, this manuscript provides a study on the crucial role of MUC1 mucin and its structure in oral lubrication. The presence of MUC1 enhances lubrication by improving the retention of salivary proteins on the cell surface. Secondly, the manuscript explores molecular mechanisms of astringency. In vitro tribological tests in the presence of astringent compounds show that these substances form aggregations on the epithelial surface, reducing oral lubrication. Concurrently, our work demonstrates protective mechanisms, including the dissociation of MUC1 and the interaction of proline-rich proteins with tannins, mitigating these adverse effects on lubrication. Through additional study, correlations between sensory perception and our measured physical properties are established, demonstrating the ability of our methodology to classify individuals based on their sensitivity to astringency. Finally, the last study presents the development of a new oral mucosa model aiming to reproduce mechanical and physicochemical properties of in vivo mucosa. This thesis proposes an innovative methodology for studying oral lubrication, particularly focusing on mechanisms responsible for astringency sensation through the use of mucosa models increasingly closer to physiological oral tissues
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Chan, Becky Ka Man. „Expression of beta subunit of epithelium sodium channel and cystic fibrosis transmembrane regulator in small airways obstruction in chronic obstructive pulmonary disease“. Thesis, University of British Columbia, 2008. http://hdl.handle.net/2429/4072.

Der volle Inhalt der Quelle
Annotation:
Background: Excess plugging of small airways is associated with premature death in chronic obstructive pulmonary disease (COPD). Over-expression of beta-epithelial sodium channel (β-ENaC) in airway epithelia in mice resulted in plugging of small airways while cystic fibrosis transmembrane regulator (CFTR) negatively regulated ENaC activity in cell models. Purpose: To test the hypothesis that accumulation of mucus exudates observed with the progression of COPD is related to excess airway epithelial sodium re-absorption as a result of over-expression of β-ENaC and reduced expression of CFTR by small airway epithelia. Methods: Small airway epithelial samples from frozen lungs from patients at different levels of COPD severity were isolated by laser capture microdissection (LCM). β-ENaC, CFTR, and β-actin (control) gene expression was determined by qRT-PCR and compared to expression in entire airways and lung parenchyma surrounding these airways. β-ENaC protein as well as epithelial mucin expression and mucus plugging were localized and quantified after immunohistochemical and periodic acid Schiff staining, respectively. Results: β-ENaC mRNA expression had a strong positive correlation with that of CFTR (p
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Tushar, Piyush. „The role of transmembrane mucin protein MUC1 in anoikis and in EGFR activation of human epithelial cancer cells“. Thesis, University of Liverpool, 2018. http://livrepository.liverpool.ac.uk/3018915/.

Der volle Inhalt der Quelle
Annotation:
MUC1 is a large, heavily glycosylated transmembrane mucin protein expressed on the apical membrane of normal epithelial cells. In epithelial cancer cells, however, MUC1 is overexpressed, abnormally glycosylated and loses its apical polarization, becoming expressed over the entire cell surface. Galectin-3, a β-galactoside-binding protein expressed by many types of human cells, is a natural ligand for MUC1. Recent studies by ourselves and others have revealed that the interaction between galectin-3 and MUC1 induces MUC1 cell surface polarization and the exposure of underlying smaller cell surface adhesion molecules. This leads to increased cancer cell homotypic aggregation and cancer cell (heterotypic) adhesion to vascular endothelium. Recently, mucin-1 (MUC1) was reported to be associated with epidermal growth factor receptor (EGFR) in epithelial cells. EGFR is a receptor tyrosine kinase involved in the regulation of multiple cellular process, including tumour proliferation and metastasis. Changes in MUC1, galectin-3 and EGFR expression have all, individually or in combination, been associated with poor cancer prognosis and increased tumour metastasis. Resistance of cancer cells to anoikis, a fundamental cellular process for maintaining tissue homeostasis, is a pre-requisite for metastasis. The aim of this study was to investigate the impact of MUC1 expression and the MUC1 interaction with galectin-3 and EGFR on EGFR activation and anoikis in epithelial cancer cells. It was found in this study, that overexpression of MUC1 in epithelial cells prevents initiation of anoikis in response to loss of adhesion. This effect was found to be attributed to both MUC1 extracellular and intracellular domains with predominant effect from the MUC1 extracellular domain. Reduction of MUC1 O-glycosylation by stable shRNA suppression of core 1 gal-transferase (C1GT) reduced MUC1-mediated resistance to anoikis in human colon cancer cells HCT116 and SW620. It was also found that MUC1 expression enhanced EGF-induced EGFR activation in human breast and colon cancer cells. Both the MUC1 extracellular and intracellular domains contribute to EGFR activation, again with the predominant contribution from the MUC1 extracellular domain. Thus, binding of galectin-3 to the MUC1 extracellular domain induces MUC1 cell surface polarization and increases MUC1-EGFR interaction, leading to increased EGFR homo-/hetero-dimerization and activation. These discoveries provide insight into the impact of MUC1 overexpression and MUC1 O-glycosylation on cancer cell behaviour in cancer progression and metastasis and may aid future development of novel therapeutic strategies for cancer treatment.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Syrjänen, R. (Riikka). „TIM family molecules in hematopoiesis“. Doctoral thesis, Oulun yliopisto, 2014. http://urn.fi/urn:isbn:9789526204246.

Der volle Inhalt der Quelle
Annotation:
Abstract Hematopoietic cells, i.e., erythrocytes, platelets and white blood cells, differentiate from hematopoietic stem cells in a process that is similar in vertebrates. Hematopoiesis is regulated by molecules expressed by both the hematopoietic stem and progenitor cells and the surrounding microenvironments. Knowledge of these molecules is important since many of the genes involved in normal hematopoiesis are mutated in leukemia. Furthermore, this information can be utilized in more efficient isolation and expansion of hematopoietic cells in vitro. However, these molecules are not yet sufficiently characterized. Transmembrane immunoglobulin and mucin domain (TIM) genes form a known family of immunoregulators. In mammals, TIM-4 is expressed by antigen presenting cells, while TIM-1, TIM-2 and TIM-3 are expressed by T cells, in which they regulate differentiation of TH cells. The role of TIM molecules in hematopoiesis has not yet been investigated. The aim of this thesis work was to identify and analyze novel molecules involved in embryonic hematopoiesis using chicken and mouse as model organisms. This was carried out by generating a cDNA library of hematopoietic stem and progenitor cells from embryonic chicken para-aortic region. Both previously known and novel candidate genes were identified from the library. Among them, we found homologs to tim genes. Their expression and role in hematopoiesis was studied further. TIM-2 expression was shown to be tightly governed during B cell development. It is expressed by common lymphoid progenitors and highly proliferative large-pro and large pre-B cells during both fetal liver and adult bone marrow hematopoiesis. In mouse, tim-4 expression was restricted to fetal liver CD45+F4/80+ cells. Furthermore, two distinct populations were identified: F4/80hiTIM-4hi and F4/80loTIM-4lo. The results suggest that the F4/80hiTIM-4hi cells are yolk sac-derived macrophages and the F4/80loTIM-4lo cells myeloid progenitors. This work shows for the first time that TIM family molecules are expressed during hematopoiesis. TIM-2- and TIM-4 are expressed by specific cell types during hematopoietic cell development, and in the future they may be utilized as markers in isolation of hematopoietic progenitor cells
Tiivistelmä Verisolut eli punasolut, verihiutaleet ja immuunipuolustuksessa tärkeät valkosolut kehittyvät alkion veren kantasoluista prosessissa, joka on kaikissa selkärankaisissa samankaltainen. Veren kanta- ja esisolujen sekä ympäröivän mikroympäristön tuottamat molekyylit säätelevät hematopoieesia eli verisolujen kehitystä. Näiden molekyylien tunteminen on tärkeää, sillä useat normaalia verisolujen kehitystä säätelevät geenit ovat osallisena myös verisyöpien synnyssä. Lisäksi tätä tietoa on mahdollista hyödyntää verisolujen tehokkaammassa eristämisessä ja kasvattamisessa hoitoja varten. Immuunipuolustuksen solut, kuten syöjäsolut eli makrofagit ja T-solut, ilmentävät TIM-molekyylejä (Transmembrane Immunoglobulin and Mucin). Ne toimivat immunologisen vasteen säätelyssä sekä solusyönnissä, mutta niiden roolia verisolujen kehittymisessä ei ole selvitetty aikaisemmin. Tässä väitöstutkimuksessa etsittiin uusia hematopoieesiin vaikuttavia geenejä käyttäen mallieläiminä sekä kanaa että hiirtä. Tutkimuksessa luotiin geenikirjasto kanan alkion para-aortaalisen alueen veren kanta- ja esisoluista. Kirjastosta tunnistettiin useita ennalta tiedettyjä sekä uusia verisolujen kehitykseen vaikuttavia geenejä. Tutkimuksessa analysoitiin tarkemmin kirjastosta löytyneiden TIM-geeniperheen jäsenten ilmentymistä ja roolia verisolujen kehityksessä. Tutkimuksessa osoitettiin, että TIM-2 proteiinin ilmentymistä säädellään tarkasti B-solujen kehityksen aikana. Lymfosyyttien yhteiset esisolut sekä suuret pro-B- ja pre-B-solut ilmentävät TIM-2 proteiinia B-solukehityksen aikana sekä alkion maksassa että aikuisen luuytimessä. Hiiren alkiossa tim-4 geenin ilmentyminen oli rajoittunut maksaan, jossa erottui kaksi erillistä solupopulaatiota: F4/80hiTIM-4hi ja F4/80loTIM-4lo. Tutkimuksen tulokset viittaavat siihen, että maksan F4/80hiTIM-4hi solut ovat ruskuaispussista lähtöisin olevia syöjäsoluja ja F4/80loTIM-4lo solut myeloidisen linjan esisoluja. Tämä tutkimus on ensimmäinen osoitus TIM-molekyylien ilmentymisestä kehittyvissä verisoluissa. Havaitsimme, että TIM-2 ja TIM-4-molekyylejä ekspressoidaan tietyissä soluissa verisolujen erilaistumisen aikana, joten tulevaisuudessa niitä on mahdollista käyttää merkkiproteiineina hematopoieettisten solujen esiasteita eristettäessä
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bücher zum Thema "Transmembrane mucins"

1

Pérez Reytor,, Diliana Celeste. Identificación de nuevos marcadores de virulencia en cepas no toxigénicas de vibrio parahaemolyticus. Universidad Autónoma de Chile, 2019. http://dx.doi.org/10.32457/20.500.12728/87462019dcbm7.

Der volle Inhalt der Quelle
Annotation:
Vibrio parahaemolyticus es la principal causa de gastroenteritis transmitida por mariscos en todo el mundo. La virulencia de V. parahaemolyticus se ha atribuido hasta ahora principalmente a la hemolisina directa termoestable (TDH) y la hemolisina relacionada con TDH (TRH). Recientemente el Sistema de Secreción de tipo III del cromosoma II (T3SS2), el cual codifica para varios efectores, ha sido relacionado con citotoxicidad y enterotoxicidad. Después de la aparición y posterior caída de la cepa pandémica, se han notificado casos de diarrea producidos por cepas clínicas que carecen de los genes tdh, trh y T3SS2 en muchos países, incluido Chile. Estas cepas, llamadas “no toxigénicas”, constituyen el 9-10% de los casos de diarrea a nivel mundial y aunque se han hecho avances en la descripción de los factores de virulencia de V. parahaemolyticus, la capacidad de las cepas no toxigénicas para causar enfermedad no ha sido completamente entendida. El hecho de que los genes tdh y trh se utilizan para estimar la carga de cepas patógenas en los mariscos durante el análisis de riesgo llama la atención sobre cuán fiables son estos análisis para detectar la gran variedad de cepas potencialmente patógenas presentes en las aguas y productos marinos. Por otra parte se conoce que en Vibrio, la evolución de la virulencia, parece estar estrechamente asociada a su capacidad para generar diversidad genética, en parte, a través de la modificación de la expresión génica, aunque mayoritariamente a través de transferencia genética horizontal (HGT). Con base en lo descrito anteriormente, esta propuesta hipotetiza que las cepas no toxigénicas de Vibrio parahaemolyticus han adquirido nuevos factores de virulencia mediante transferencia genética horizontal. Es por ello que el objetivo de esta tesis es: Identificar y caracterizar nuevos factores de virulencia en cepas chilenas no toxigénicas de Vibrio parahaemolyticus adquiridos mediante transferencia génica horizontal. Esta tesis está organizada en tres capítulos, el capítulo 1 comprende el marco teórico, el planteamiento del problema, la hipótesis y los objetivos. El capítulo 2, correspondiente al desarrollo del objetivo 1, en el cual se caracteriza el genoma de seis cepas no toxigénicas de V. parahaemolyticus aisladas del Sur de Chile. Uno de los principales hallazgos de este estudio fue la variabilidad genética de estas cepas al analizar su genoma accesorio. Este análisis mostró además la presencia de nuevas islas genómicas y elementos tipo profagos que codifican toxinas como zonula occludens (Zot) y repeats-in-toxin (RTX), ambas descritas en otros patógenos como V. cholerae donde se consideran factores de virulencia, aunque últimamente se ha descrito que la pérdida de RTX no afecta la virulencia de esta bacteria. En el capítulo 3 y final de esta tesis, se aborda el objetivo 2 que corresponde a la caracterización de posibles nuevos factores de virulencia, en este caso, la toxina Zonula Occludens (Zot). Aunque se sabe que Zot aumenta la permeabilidad epitelial intestinal por interacción con el receptor celular de zonulina PAR2 y esta unión desencadena una cascada de eventos intracelulares que conducen al desensamblaje de las uniones estrechas intercelulares, lo que se ha asociado con la producción de la diarrea en V. cholerae, el potencial patógeno de Zot de V. parahaemolyticus no se ha investigado aún. La cepa clínica PMC53.7, tdh/trh/T3SS2/negativa, resultó ser altamente citotóxica en cultivo celular de Caco-2 y contiene en su genoma accesorio un gen homólogo de zot. Con este antecedente, se caracterizó la toxina Zot en la cepa clínica PMC53.7 de V. parahaemolyticus y sus efectos sobre la barrera epitelial intestinal. El gen zot de PMC53.7 se clonó y se expresó en Escherichia coli BL21(DE3) y los efectos sobre la barrera epitelial intestinal se examinaron usando el modelo celular Caco-2. Se evaluó el cambio en la distribución de las proteínas de transmembrana asociadas a uniones estrechas (ZO-1 y ocludina), y en la distribución de actina en monocapas de Caco-2. Tras el tratamiento con Zot, se observó una modificación de la morfología celular. El cambio en las distribuciones de ocludina y F-actina se observó como una fragmentación de los límites brillantes de las células, con áreas de baja y alta intensidad, lo que indica una pérdida y redistribución de las proteínas asociadas a uniones estrechas. Los resultados de este trabajo sugieren que V. parahaemolyticus Zot puede contribuir a la virulencia de cepas no toxigénicas. En resumen, estos estudios han arrojado información sobre la diversidad de cepas de V. parahaemolyticus del sur del Pacífico, en especial aquellas que no poseen los principales factores de virulencia descritos para este microorganismo. Además, se caracteriza por primera vez una toxina Zot de V. parahaemolyticus en una cepa aislada de un paciente. Finalmente, los ensayos preliminares realizados en cultivo celular demostraron un posible potencial patógeno de esta toxina en la barrera epitelial intestinal.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Buchteile zum Thema "Transmembrane mucins"

1

Constantinou, Pamela E., Micaela Morgado und Daniel D. Carson. „Transmembrane Mucin Expression and Function in Embryo Implantation and Placentation“. In Regulation of Implantation and Establishment of Pregnancy in Mammals, 51–68. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-15856-3_4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Aydin Acar, Cigdem. „Cystic Fibrosis: Clinical Characteristics, Molecular Mechanisms and Treatment“. In Molecular Approaches in Medicine, 135–51. Istanbul: Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359524.7.

Der volle Inhalt der Quelle
Annotation:
Cystic Fibrosis (CF) is a genetic disorder that primarily affects the respiratory and digestive systems. This chapter provides a comprehensive overview of CF, including its pathophysiology, clinical manifestations, diagnosis and treatment. CF is caused by mutations in the CFTR gene, which encodes the cystic fibrosis transmembrane conductance regulator protein. This protein is crucial for the regulation of chloride and sodium ions across epithelial membranes. Mutations lead to the production of thick, sticky mucus that clogs the airways and various channels throughout the body. This chapter describes the main symptoms of CF, including chronic cough, progressive lung damage due to recurrent lung infections, and gastrointestinal problems such as pancreatic enzyme deficiency, malabsorption, and meconium ileus in newborns. CF can also affect the liver, sweat glands, and reproductive system. Diagnostic criteria for CF are discussed and the importance of newborn screening, sweat chloride testing, and genetic testing is emphasized. This chapter also reviews current treatment options aimed at managing symptoms and improving quality of life. The role of CFTR modulators, a new class of drugs targeting the underlying genetic disorder, is also highlighted and concludes with a discussion of new therapies and ongoing research aimed at finding a cure for CF.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

„Transmembrane Mucin 1“. In Encyclopedia of Signaling Molecules, 5680. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_103949.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Robinson, Chapman. „Cystic fibrosis (CF)“. In Oxford Handbook of Respiratory Medicine, herausgegeben von Stephen J. Chapman, Grace V. Robinson, Rahul Shrimanker, Chris D. Turnbull und John M. Wrightson, 237–60. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198837114.003.0024.

Der volle Inhalt der Quelle
Annotation:
Cystic fibrosis (CF) is a multi-system disease due to mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), a complex chloride channel. CFTR is essential for regulating chloride permeability across epithelial tissues and, in addition, has other complex cellular roles. Loss of CFTR function or quantity causes inadequate hydration of mucous secretions. In the lungs this results in defective mucociliary clearance, mucus obstruction of the luminal space, and colonization with pathogenic bacteria. Recurrent cycles of infection and inflammation contribute to lung damage and subsequent development of bronchiectasis. In the pancreas, the exocrine ducts become blocked by secretions, leading to pancreatic destruction, pancreatic enzyme insufficiency, and CF-related diabetes.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Transmembrane mucins"

1

Maher, Diane M., Phillip Stephenson, Brij K. Gupta, Nichole A. Bauer, Michael Koch, Susan Eliason, Meena Jaggi und Subhash C. Chauhan. „Abstract 3589: Comparative expression profile of transmembrane mucin MUC1 in breast cancer from American Indian and Caucasian women“. In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-3589.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Abraham, William, Juan Sabater und Tahir Ahmed. „Allosteric inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) slows airway mucus transport in normal sheep“. In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2054.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!